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Abstract
Background: Thymoquinone is an active principle of Nigella sativa seed known as “Habbah Al-Sauda” in Arabic
countries and “Sinouj” in Tunisia. Bacterial biofilms tend to exhibit significant tolerance to antimicrobials drugs
during infections.
Methods: The antibacterial activity of Thymoquinone (TQ) and its biofilm inhibition potencies were investigated on
11 human pathogenic bacteria. The growth and development of the biofilm were assessed using the crystal violet
(CV) and the 2, 3-bis [2-methyloxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) reduction assay.
Results: TQ exhibited a significant bactericidal activity against the majority of the tested bacteria (MICs values
ranged from 8 to 32 μg/ml) especially Gram positive cocci (Staphylococcus aureus ATCC 25923 and Staphylococcus
epidermidis CIP 106510). Crystal violet assay demonstrated that the minimum biofilm inhibition concentration
(BIC50) was reached with 22 and 60 μg/ml for Staphylococcus aureus ATCC 25923 and Staphylococcus epidermidis
CIP 106510 respectively. In addition our data revealed that cells oxidative activity was influenced by TQ
supplementation. In the same way, TQ prevented cell adhesion to glass slides surface.
Conclusion: The ability of TQ to prevent biofilm formation warrants further investigation to explore its use as
bioactive substances with antibiofilm potential.
Background
A biofilm is a community of cells attached to biotic or
abiotic surface [1,2]. It allows micro-organisms to
survive in hostile environmental conditions [2]. Patho-
genic bacteria released from the biofilm lead to food
hygiene problems [3]. Conventional methods for
biofilm removal are generally inadequate. Biofilm for-
mation required the polysaccharide intercellular adhe-
sion which contributed to cells protection against host
immune system [4,5].
Prevention of biofilm formation effect of plants has
been largely reported against Listeria monocytogenes [6],
Pseudomonas aeruginosa [7], Streptococcus mutans
[8-10], Staphylococcus aureus [11,12], Candida albicans
[13] and oral pathogens [14]. The presence of rich
biological active compounds in Nigella sativa volatile oil
has highlighted its traditional medicinal use [15]. Black
seed of Nigella sativa L. have been used in Middle East-
ern folk medicine as a natural remedy for various diseases
for over 2000 years [16]. Many active principles have
been isolated from Nigella sativa seed [17] including thy-
moquinone (TQ). TQ (2-isopropyl-5-methyl-1,4-benzo-
quinone) was the bioactive constituent of this oil [18]
showing antibacterial [19,20] and antifungal activity [21].
In addition a great antibacterial action of TQ against
Paenibacillus larvae was observed (MIC values ranging
from 8 to 16 mg/ml) [22]. Alkharfy et al., [23] reported
that TH treatment reduced mortality in mice following
Lipopolysaccharid and live Esherichia coli challenge by
80-90%. More recently, TQ inhibits the proliferation of
MCF-7/DOX cells [24].
This study was undertaken to investigate the in vitro
antibacterial activity of TQ and its potency to prevent
biofilm formation against human pathogenic bacteria.
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Methods
Organisms and chemicals
In this study, the antibacterial activity of TQ was tested
on 11 Human pathogenic strains including Gram nega-
tive bacilli: Escherichi coli ATCC 35218, Salmonella
enterica serovar Typhimurium ATCC 14028, Pseudomo-
nas aeruginosa ATCC 27853, Vibrio alginolyticus ATCC
33787, Vibrio paraheamolyticus ATCC 17802; Gram
positive bacilli: Bacillus cereus ATCC 14579, Listeria
monocytogene ATCC 19115 and Gram positive cocci:
Enterococcus faecalis ATCC 29212, Micrococcus luteus
NCIMB 8166, Staphylococcus aureus ATCC 25923, Sta-
phylococcus epidermidis CIP 106510 (Table 1).
TQ, gentamycin and erythromycin was purchased
from Sigma (Sigma-Aldrich, Switzerland).
Minimum inhibitory concentration determination
The broth microdilution method was used to determine
the minimum inhibitory concentration (MIC) and mini-
mum bactericidal concentration (MBC) of TQ (0 to 512
μg/ml), gentamycin (0 to 256 μg/ml) and erythromycin
(0 to 256 μg/ml) as recommended by the National Com-
mittee for Clinical Laboratory Standards Institute [25].
An overnight culture (37°C) of the tested strains were
diluted 10-fold in fresh tryptic soy broth (TSB) and
incubated (37°C) until they reached exponential growth
phase. Serial two-fold dilutions of TQ in Mueller Hinton
(MH) Broth (Biorad, France) were prepared in a 96-
wells plate (190 μL per well).
The inocula (10 μL) containing 5. 106 cfu/ml of each
reference strain were added to each well and the tested
compound. A number of wells were reserved in each
plate to test the sterility control of the medium (no
inoculum added) and inoculum viability (no compound
added).
After incubation for 24 h at 37°C, bacterial growth
was evaluated by the presence of turbidity and a pellet
on the well bottom. The MIC was defined as the con-
centration that completely inhibited visible cell growth
during a 24-h incubation period at 37°C
Minimum bactericidal concentration determination
To determine the minimum bactericidal concentration
(MBC) values, 10 μL of each well medium with no visi-
ble growth was removed and inoculated in MH plates.
After 24 h of incubation at 37°C, the number of surviv-
ing organisms was determined. MBC was defined as the
lowest concentration at which 99% of the bacteria were
killed. Each experiment was repeated at least twice [26].
Effect of Thymoquinone on biofilm formation
Crystal Violet assay
TQ was tested for its potential to prevent biofilm forma-
tion of four reference strains (Table 2). The TQ was
added to the growth medium at the time of inoculation
and the cells were allowed to form biofilms [6]. Preven-
tion of biofilm formation by TQ was examined by
microdilution, similar to the MIC assay for planktonic
cells. A two-fold serial dilution was prepared in 96-well
polystyrene tissue culture plates containing TSB broth
with 2% glucose (w/v), with final concentrations of TQ
ranging from 0 to 512 μg/ml.
The medium without TQ was used as the non-treated
well and the medium with TQ as the blank control.
Table 1 Antibacterial activity of thymoquinone against Human pathogenics strains
Strains Antimicrobial susceptibility
Gentamycin (μg/ml) Erythromycin (μg/ml) Thymoquinone (μg/ml)
aMIC bMBC MIC MBC MIC MBC
Gram negative bacilli
Escherichi coli ATCC 35218 8 16 32 64 >512 >512
Pseudomonas aeruginosa ATCC 27853 2 4 256 >256 >512 >512
Salmonella enterica serovar Typhimurium ATCC 14028 2 8 >256 >256 >512 >512
Vibrio alginolyticus ATCC 33787 32 64 >256 >256 256 >512
Vibrio paraheamolyticus ATCC 17802 8 16 128 256 32 64
Gram positive bacilli
Bacillus cereus ATCC 14579 4 8 8 16 8 8
Listeria monocytogene ATCC 19115 2 4 1 4 16 32
Gram positive cocci
Enterococcus faecalis ATCC 29212 32 64 256 >256 32 64
Micrococcus luteus NCIMB 8166 2 8 4 16 8 64
Staphylococcus aureus ATCC 25923 16 32 16 32 8 16
Staphylococcus epidermidis CIP 106510 4 8 16 32 8 8
a, Minimum inhibitory concentration.
b, Minimum bactericidal concentration.
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Aliquots of bacterial suspension (10 μl) were inoculated
in tissue culture plate wells (5.104 cfu/ml, final concen-
tration). Following incubation at 37°C for 24h, culture
supernatants from each well were decanted and plank-
tonic cells were removed by washing three times with
phosphate-buffered saline (7 mM Na2HPO4, 3 mM
NaH2PO4 and 130 mM NaCl at pH 7.4). Cells in biofilm
were fixed with methanol during 15 min, air dried and
stained with 1% crystal violet [27]. Biofilm formation
was quantified by measuring the absorbance at 595 nm
using a microplate reader (GIO. DE VITA E C, Italy).
In order to asses the ability of TQ to prevent biofilm
formation, the percentage of biofilm inhibition was cal-
culated using the equation [(OD growth control _ OD
sample)/OD growth control] × 100 [6]. Each assay was
repeated three times.
The minimum biofilm inhibition concentration
(MBIC50) was defined as the lowest concentration of
TQ that showed 50% inhibition on the biofilm
formation.
Assessment of biofilm metabolic activity using XTT
reduction assay
The metabolic activity of cells in biofilm was assessed
using the XTT [2, 3-bis (2-methyloxy-4-nitro-5-sulfo-
phenyl)-2H-tetrazolium-5-carboxanilide] reduction assay
according to methods described previously [6,28] which
measures the reduction of a tetrazolium salt by metabo-
lically active cells to a coloured water soluble formazan
derivative that can be easily quantified colorimetrically.
A two-fold serial dilution of TQ (final concentrations
from 0 to 512 μg/ml) was prepared in 96-well polystyr-
ene tissue culture plates containing TSB broth with 2%
glucose (w/v). Than the plates were inoculated in the
same way as described for crystal violet assay.
XTT (Sigma-Aldrich, Switzerland) solution (1 mg/ml)
was prepared in PBS, filter sterilized and stored at -80°
C. Menadione (Sigma-Aldrich, Switzerland) solution
(1 mM) was prepared in acetone and sterilized immedi-
ately before each assay.
Following incubation, the biofilms were first washed
five times with PBS, and then 100 μl PBS and 12 μl
XTT-menadione solution (12.5:1 v/v) were added to each
of the prewashed wells and the control wells. The plate
was then incubated for 3 h in the dark at 37°C. Following
incubation, 100 μl of the solution was transferred to fresh
wells, and the colour change in the solution was mea-
sured with a multiskan reader at 492 nm. The absorbance
values for the controls were then subtracted from the
values of the tested wells to eliminate spurious results
due to background interference.
The percentage of biofilm inhibition was calculated
using the equation [(OD growth control _ OD sample)/
OD growth control] × 100. Each assay was repeated
three times.
Microscopic techniques
Prevention of biofilm formation by TQ was confirmed
by microscopic technique. Briefly, strains were allowed
to grow on round covers glass slides (diameter 1 cm)
placed in 24-well polystyrene plates (Greiner Bio-One,
France) supplemented with TQ (0, MIC, 2 × MIC),
incubated for 24 h at 37°C and stained with 1/20
Giemsa (Sigma, Switzerland) solution (v/v) for 20 min at
room temperature. Stained glass pieces were placed on
slides with the biofilm pointing up and were inspected
by light microscopy at magnifications X100.
Statistical analysis
Statistical analysis was performed on SPSS v.17.0
statistics software. Statistical differences and signifi-
cance were assessed by one-way ANOVA test and Wil-
coxon signed ranks test, as appropriate, to evaluate the
biofilm inhibition according the type of strains and the
TQ supplementation. A P value < 0.05 was considered
significant.
Results
Effect of thymoquinone on viability of planktonic cells
TQ demonstrated selective antimicrobial properties. As
presented in table 1, it exhibited bactericidal activity on
7 out of 11 tested strains with MIC and MBC values
ranging from 8 to 32 μg/ml and 8 to 64 μg/ml, respec-
tively. This activity is nearly similar to the tested
Table 2 Antibiofilm effect of thymoquinone against four positive biofilm strains
Strains Inhibition of biofilm development (%)
Crystal Violet assay XTT assay
aBIC50 (μg/ml) bBIC90 (μg/ml) BIC50 (μg/ml) BIC90 (μg/ml)
Enterococcus faecalis ATCC 29212 85 349 44 145
Staphylococcus aureus ATCC 25923 22 75 20.5 51
Staphylococcus epidermidis CIP 106510 60 109 40 90
Pseudomonas aeruginosa ATCC 27853 >512 >512 >512 >512
a, minimum biofilm inhibition concentration of TQ that showed 50% inhibition on the biofilm formation.
b, minimum biofilm inhibition concentration of TQ that showed 90% inhibition on the biofilm formation.
Chaieb et al. BMC Complementary and Alternative Medicine 2011, 11:29
http://www.biomedcentral.com/1472-6882/11/29
Page 3 of 6
antibiotics (gentamycin and erythromycin). However,
Gram negative bacilli (Escherichia coli ATCC 35218, Sal-
monella enterica serovar Typhimurium ATCC 14028,
Pseudomonas aeruginosa ATCC 27853), seem to be resis-
tant to TQ action (MIC and MBC > 512 μg/ml). We
noted also that the MBC values of TQ were 2-4 times
higher than the MICs values.
Inhibition of biofilm formation
Crystal violet assay
Prevention of biofilm formation by TQ was tested on
four positive strains (Table 2). Results were expressed as
inhibition percentages of biofilm development. TQ
showed a significant inhibitory effect (P < 0.05) on bio-
film formation of Staphylococcus epidermidis CIP
106510 and Staphylococcus aureus ATCC 25923 with a
dose dependent manner.
As presented in table 2, the lower BIC50 of TQ was
observed for Staphylococcus aureus ATCC 25923 (22
μg/ml), followed by Staphylococcus epidermidis CIP
106510 (60 μg/ml) and Enterococcus feacalis ATCC
29212 (85 μg/ml).
Our results demonstrated that TQ induced prevention
of 90% of biofilm formation of Staphylococcus aureus
ATCC 25923, Staphylococcus epidermidis CIP 106510
and Enterococcus faecalis ATCC 29212 when used at 75,
109 and 349 μg/ml respectively, suggesting that its
strong biofilm inhibition potencies is not restricted to
staphylococci. However, our data showed also that TQ
do not prevent 50% of biofilm formation in the case of
Pseudomonas aeruginosa ATCC 27853.
Effect of thymoquinone on biofilm oxidative activity
In the presence of TQ, the metabolic oxidative activity
of cells in biofilms was distinctly reduced after 24 h of
incubation (Table 2). Our data also provides preliminary
evidence that TQ affect the oxidative activity of all the
tested strains compared to the non treated biofilm
(Table 2).
The BIC50 was observed with TQ concentration about
20.5, 40 and 44 μg/ml for Staphylococcus aureus ATCC
25923; Staphylococcus epidermidis CIP 106510; and
Enterococcus faecalis ATCC 29212 respectively (Table 2).
Moreover, BIC90 was very low (51, 90 and 145 μg/ml)
suggesting that TQ is efficient for prevention of biofilm
formation. We noted also that Pseudomonas aeruginosa
ATCC 27853 was less susceptible to TQ than the others
strains. A statistical significant difference in prevention
of biofilm formation between the treated strains with TQ
(> 4 μg/ml) and control was found (P < 0.001). These
results indicated that in addition to reducing the number
of adherent bacteria assessed by crystal violet assay, TQ
has an effect on the metabolic activity of cells embedded
in biofilm.
Prevention of biofilm formation on glass microscope slide
covers
Prevention of biofilm formation by TQ was confirmed
by microscopic visualization. As shown in figure 1, a
moderate reduction of biofilm formation was observed
with TQ supplementation (1 MIC) on the strong biofilm
formers (Staphylococcus aureus ATCC 25923 and Sta-
phylococcus epidermidis CIP 106510) whereas the bio-
film former was significantly inhibited with 2 × MIC
TQ supplementation. With this last concentration, the
biofilm former of Enterococcus faecalis ATCC 29212
and Pseudomonas aeruginosa ATCC 27853 decreased
but was not wholly suppressed.
Discussion
Based on our present results, TQ exhibited a selective
antibacterial effect against seven bacteria, particularly
Gram positive strains with low MICs values (Table 1).
This result correlate with Kokoska et al., [29] who
reported that Thymoquinone exhibited potent growth-
inhibitory effect against Gram-positive bacteria, with





Figure 1 Microscopic visualization of the effect of
thymoquinone on four biofilm positives strains cultured on
glass slides covers. Prevention of biofilm formation effect of TQ
was as followed: For S. aureus ATCC 25923 a, non treated slides; aa,
cells supplemented with TQ MIC; aaa, cells supplemented with TQ 2
× MIC. For S. epidermidis CIP 106510, b, positive control (non treated
slides); bb, cells supplemented with TQ MIC; bbb, cells
supplemented with TQ 2 × MIC.For E. faecalis ATCC 29212, c, non
treated slides; cc, cells supplemented with TQ MIC; ccc, cells
supplemented with TQ 2 × MIC. For P. aeruginosa ATCC 27853, d,
non treated slides; dd, cells supplemented with TQ MIC; ddd, cells
supplemented with TQ 2 × MIC.
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Bacteria in biofilm have been shown to be much more
resistant to antibiotics than their planktonic form [30].
The success of natural compounds in inhibiting cell
attachment is a promising tool for reducing microbial
colonization on various surfaces [31]. Application of
anti-adhesion agents appears to be a very interesting
approach in the prevention of microbial infection
[32,33].
In order to find a natural compound able to inhibit
and prevent microbial biofilm formation, we tested the
effect of TQ on four biofilm positives strains. Crystal
violet assay showed that TQ reduce the number of
adherent bacteria and the BIC50 was reached with 22
and 60 μg/ml for Staphylococcus aureus ATCC 25923
and Staphylococcus epidermidis CIP 106510 respectively
(Table 2).
We noted also that the medium supplemented with 75
μg/ml of TQ induce 90% biofilm inhibition in the case
of Staphylococcus aureus ATCC 25923 (Table 2). For
Enterococcus feacalis ATCC 29212 and Pseudomonas
aeruginosa ATCC 27853, BICs90 was higher than 100
μg/ml.
A statistically significant inhibitory effect on biofilm
formation by Staphylococcus aureus ATCC 25923 and
Staphylococcus epidermidis CIP 106510 was noted after
TQ supplementation (P < 0.001).
Prevention of biofilm formation by TQ was also con-
firmed using XTT assay. At 51 μg/ml TQ supplementa-
tion, it exhibited a significant biofilm inhibition
percentage of Staphylococcus aureus ATCC 25923 that
was more than 90% (Table 2). In addition BIC90 was
reached with 90 and 145 μg/ml supplementation for
Staphylococcus epidermidis CIP 106510 and Enterococ-
cus faecalis ATCC 29212 respectively (Table 2). The
Wilcoxon signed ranks test showed a statistical signifi-
cant difference between the none treated and the treated
cells with concentrations over 4 μg/ml (P < 0.001). Most
antibiotics are up to 1000-times less efficient against
bacteria in biofilm than in suspension [34], which makes
TQ a very promising treatment alternative.
Inhibition of biofilm formation assessed by XTT do
not correlate with crystal violet assay, similar result has
been reported for plant extracts between the biomass
and metabolic activity [6].
Our results revealed that TQ efficiently kills staphylo-
cocci in suspension and prevent biofilms formation.
This effect on biofilm formation was confirmed by
microscopic analysis of strains grown on the surface of
glass slides covers. We observed a biofilm inhibition
when we inoculated the strain with a concentration of
TQ equal to MIC and 2 × MIC. Statistical analysis
revealed a significant difference between the percentage
of biofilm inhibition obtained after TQ supplementation
(2 × MIC) between treated cells and non treated ones
(P < 0.001).
Conclusion
TQ significantly affects pathogenic bacteria at low con-
centrations. Its antimicrobial and biofilm inhibition
potencies allows us to suggest its inclusion in the
arsenal of bioactive substances and subjecting it to
further research, such as in vivo compatibility tests in
many biological models. However, further work needs to
be done to determine the main mechanism by which
TQ affect biofilm formation.
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